| Date | Form | Description | Docs | XBRL | Pages |
| 01/27/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/23/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/23/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/23/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/17/14 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
|
6 |
| 01/16/14 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
111 | |
| 01/06/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...